Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis

被引：1699

作者：

Clarke, R ^{[1
]}

Collins, R ^{[1
]}

Lewington, S ^{[1
]}

Donald, A ^{[1
]}

Alfthan, G ^{[1
]}

Tuomilehto, J ^{[1
]}

Arnesen, E ^{[1
]}

Bonaa, K ^{[1
]}

Blacher, J ^{[1
]}

Boers, GHJ ^{[1
]}

Bostom, A ^{[1
]}

Bots, ML ^{[1
]}

Grobee, DE ^{[1
]}

Brattström, L ^{[1
]}

Breteler, MMB ^{[1
]}

Hofman, A ^{[1
]}

Chambers, JC ^{[1
]}

Kooner, JS ^{[1
]}

Coull, BM ^{[1
]}

Evans, RW ^{[1
]}

Kuller, LH ^{[1
]}

Evers, S ^{[1
]}

Folsom, AR ^{[1
]}

Freyburger, G ^{[1
]}

Parrot, F ^{[1
]}

Genst, J ^{[1
]}

Dalery, K ^{[1
]}

Graham, IM ^{[1
]}

Daly, L ^{[1
]}

Hoogeveen, EK ^{[1
]}

Kostense, PJ ^{[1
]}

Stehouwer, CDA ^{[1
]}

Hopknis, PN ^{[1
]}

Jacques, P ^{[1
]}

Selhub, J ^{[1
]}

Luft, FC ^{[1
]}

Jungers, P ^{[1
]}

Lindgren, A ^{[1
]}

Lolin, YI ^{[1
]}

Loehrer, F ^{[1
]}

Fowler, B ^{[1
]}

Mansoor, MA ^{[1
]}

Malinow, MR ^{[1
]}

Ducimetiere, P ^{[1
]}

Nygard, O ^{[1
]}

Refsum, H ^{[1
]}

Vollset, SE ^{[1
]}

Ueland, PM ^{[1
]}

Omenn, GS ^{[1
]}

Beresford, SAA ^{[1
]}

机构：

[1] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 16期

关键词：

D O I：

10.1001/jama.288.16.2015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Context it has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke. Objective To assess the relationship of homocysteine concentrations with vascular disease risk. Data Sources MEDLINE was searched for articles published from January 1966 to January 1999. Relevant studies were identified by systematic searches of the literature for all reported observational studies of associations between IHD or stroke risk and homocysteine concentrations. Additional studies were identified by a hand search of references of original articles or review articles and by personal communication with relevant investigators. Study Selection Studies were included if, they had data available by January 1999 on total blood homocysteine concentrations, sex, and age at event. Studies were excluded if they measured only blood concentrations of free homocysteine or of homocysteine after a methionine-loading test or if relevant clinical data were unavailable or incomplete. Data Extraction Data from 30 prospective or retrospective studies involving a total of 5073 IHD events and 1113 stroke events were included in a meta-analysis of individual participant data, with allowance made for differences between studies, for confounding by known cardiovascular risk factors, and for regression dilution bias. Combined odds ratios (ORs) for the association of IHD and stroke with blood homocysteine concentrations were obtained by using conditional logistic regression. Data Synthesis Stronger associations were observed in retrospective studies of homocysteine measured in blood collected after the onset of disease than in prospective studies among individuals who had no history of cardiovascular disease when blood was collected. After adjustment for known cardiovascular risk factors and regression dilution bias in the prospective studies, a 25% lower usual (corrected for regression. dilution bias) homocysteine level (about 3 mumol/L [0.41 mg/L]) was associated with an 11% (OR, 0.89; 95% confidence interval [CI], 0.83-0.96) lower IHD risk and 19% (OR, 0.81; 95% CI, 0.69-0.95) lower stroke risk. Conclusions This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on disease risk of genetic variants that affect blood homocysteine concentrations will help determine whether homocysteine is causally related to vascular disease, as may large randomized trials of the effects on IHD and stroke of vitamin supplementation to lower blood homocysteine concentrations.

引用

页码：2015 / 2022

页数：8

共 73 条

[1] RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].

ALFTHAN, G ;

PEKKANEN, J ;

JAUHIAINEN, M ;

PITKANIEMI, J ;

KARVONEN, M ;

TUOMILEHTO, J ;

SALONEN, JT ;

EHNHOLM, C .

ATHEROSCLEROSIS, 1994, 106 (01) :9-19

[2] INFLUENCE OF HYDROLYSIS ON PLASMA HOMOCYSTEINE DETERMINATION IN HEALTHY-SUBJECTS AND PATIENTS WITH MYOCARDIAL-INFARCTION [J].

ANDERSSON, A ;

ISAKSSON, A ;

BRATTSTROM, L ;

ISRAELSSON, B ;

HULTBERG, B .

ATHEROSCLEROSIS, 1991, 88 (2-3) :143-151

[3] SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].

ARNESEN, E ;

REFSUM, H ;

BONAA, KH ;

UELAND, PM ;

FORDE, OH ;

NORDREHAUG, JE .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709

[4]

Blacher J, 1996, ARCH MAL COEUR VAISS, V89, P1241

[5] HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].

BOERS, GHJ ;

SMALS, AGH ;

TRIJBELS, FJM ;

FOWLER, B ;

BAKKEREN, JAJM ;

SCHOONDERWALDT, HC ;

KLEIJER, WJ ;

KLOPPENBORG, PWC .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715

[6] Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women [J].

Bostom, AG ;

Silbershatz, H ;

Rosenberg, IH ;

Selhub, J ;

D'Agostino, RB ;

Wolf, PA ;

Jacques, PF ;

Wilson, PWF .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1077-1080

[7] Homocysteine and short-term risk of myocardial infarction and stroke in the elderly -: The Rotterdam study [J].

Bots, ML ;

Launer, LJ ;

Lindemans, J ;

Hoes, AW ;

Hofman, A ;

Witteman, JCM ;

Koudstaal, PJ ;

Grobbee, DE .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) :38-44

[8] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[9]

Brattström L, 2000, AM J CLIN NUTR, V72, P315

[10]

Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894

← 1 2 3 4 5 6 7 8 →